Jane E. Allan

1.9k total citations
53 papers, 1.6k citations indexed

About

Jane E. Allan is a scholar working on Immunology, Epidemiology and Hepatology. According to data from OpenAlex, Jane E. Allan has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 23 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Jane E. Allan's work include Immune Cell Function and Interaction (23 papers), Cytomegalovirus and herpesvirus research (13 papers) and Immunotherapy and Immune Responses (11 papers). Jane E. Allan is often cited by papers focused on Immune Cell Function and Interaction (23 papers), Cytomegalovirus and herpesvirus research (13 papers) and Immunotherapy and Immune Responses (11 papers). Jane E. Allan collaborates with scholars based in Australia, United States and France. Jane E. Allan's co-authors include Peter C. Doherty, G. R. Shellam, Rhodri Ceredig, Felicity Lynch, J. M. Papadimitriou, Gregory J. Bancroft, Christopher M. Snyder, Ann B. Hill, Zsuzsanna Tabi and J. E. Grundy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Jane E. Allan

53 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane E. Allan Australia 22 1.0k 795 205 152 117 53 1.6k
J. E. Grundy United Kingdom 22 966 0.9× 1.1k 1.4× 236 1.2× 230 1.5× 123 1.1× 31 1.9k
Kurt H. Edelmann United States 11 1.0k 1.0× 504 0.6× 380 1.9× 154 1.0× 220 1.9× 16 1.7k
Uday Kumaraguru United States 10 856 0.8× 350 0.4× 92 0.4× 99 0.7× 84 0.7× 13 1.1k
Ivan Bubić Croatia 15 1.0k 1.0× 987 1.2× 156 0.8× 222 1.5× 149 1.3× 27 1.5k
R M Zinkernagel Switzerland 17 1.6k 1.5× 410 0.5× 253 1.2× 189 1.2× 250 2.1× 29 2.1k
Pietro Pala United Kingdom 17 776 0.7× 386 0.5× 133 0.6× 95 0.6× 268 2.3× 30 1.3k
Lisa L. Lau United States 14 1.6k 1.5× 275 0.3× 155 0.8× 193 1.3× 238 2.0× 16 2.0k
O Marker Denmark 24 1.3k 1.3× 385 0.5× 291 1.4× 194 1.3× 89 0.8× 46 1.7k
Sam Hou United States 22 1.9k 1.8× 800 1.0× 332 1.6× 278 1.8× 219 1.9× 35 2.5k
Florence Tilloy France 7 2.0k 1.9× 519 0.7× 123 0.6× 255 1.7× 198 1.7× 9 2.3k

Countries citing papers authored by Jane E. Allan

Since Specialization
Citations

This map shows the geographic impact of Jane E. Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Allan more than expected).

Fields of papers citing papers by Jane E. Allan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane E. Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Allan. The network helps show where Jane E. Allan may publish in the future.

Co-authorship network of co-authors of Jane E. Allan

This figure shows the co-authorship network connecting the top 25 collaborators of Jane E. Allan. A scholar is included among the top collaborators of Jane E. Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane E. Allan. Jane E. Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackaman, Connie, Sally M. Lansley, Jane E. Allan, B. W. Robinson, & Delia J. Nelson. (2012). IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase. International Immunology. 24(6). 357–368. 20 indexed citations
2.
Snyder, Christopher M., et al.. (2011). Sustained CD8+ T Cell Memory Inflation after Infection with a Single-Cycle Cytomegalovirus. PLoS Pathogens. 7(10). e1002295–e1002295. 90 indexed citations
3.
Snyder, Christopher M., et al.. (2010). Cross-Presentation of a Spread-Defective MCMV Is Sufficient to Prime the Majority of Virus-Specific CD8+ T Cells. PLoS ONE. 5(3). e9681–e9681. 61 indexed citations
4.
5.
MacQuillan, Gerry, Xianwa Niu, David Speers, et al.. (2004). Does sequencing the PKRBD of hepatitis C virus NS5A predict therapeutic response to combination therapy in an Australian population?. Journal of Gastroenterology and Hepatology. 19(5). 551–557. 17 indexed citations
6.
MacQuillan, Gerry, Cyril Mamotte, W D Reed, Gary P. Jeffrey, & Jane E. Allan. (2003). Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection. Journal of Medical Virology. 70(2). 219–227. 56 indexed citations
7.
MacQuillan, Gerry, W. Bastiaan de Boer, Kieran McCaul, et al.. (2002). Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection. Journal of Medical Virology. 68(2). 197–205. 34 indexed citations
8.
9.
Lathbury, Louise J., Jane E. Allan, G. R. Shellam, & Anthony A. Scalzo. (1996). Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. Journal of General Virology. 77(10). 2605–2613. 48 indexed citations
10.
Lyons, Paul, et al.. (1996). Effect of natural sequence variation at the H-2Ld-restricted CD8+ T cell epitope of the murine cytomegalovirus ie1-encoded pp89 on T cell recognition. Journal of General Virology. 77(10). 2615–2623. 17 indexed citations
11.
Davé, Vibhuti P., Jane E. Allan, Karen S. Slobod, et al.. (1994). Viral Cross-Reactivity and Antigenic Determinants Recognized by Human Parainfluenza Virus Type 1-Specific Cytotoxic T-Cells. Virology. 199(2). 376–383. 27 indexed citations
12.
Slobod, Karen S., et al.. (1993). T-Cell Receptor Heterogeneity among Epstein-Barr Virus-Stimulated T-Cell Populations. Virology. 196(1). 179–189. 11 indexed citations
13.
Allan, Jane E. & Peter C. Doherty. (1990). Binding of Monoclonal Antibodies and T Cell Effector Function In Vivo. Hybridoma. 9(1). 9–15. 2 indexed citations
14.
Doherty, Peter C., Jane E. Allan, & Rhodri Ceredig. (1988). Contributions of host and donor T cells to the inflammatory process in murine lymphocytic choriomeningitis. Cellular Immunology. 116(2). 475–481. 20 indexed citations
15.
Tabi, Zsuzsanna, Felicity Lynch, Rhodri Ceredig, Jane E. Allan, & Peter C. Doherty. (1988). Virus-specific memory T cells are Pgp-1+ and can be selectively activated with phorbol ester and calcium lonophore. Cellular Immunology. 113(2). 268–277. 57 indexed citations
16.
Uren, M. F., Peter C. Doherty, & Jane E. Allan. (1987). Flavivirus-specific Murine L3T4+ T Cell Clones: Induction, Characterization and Cross-reactivity. Journal of General Virology. 68(10). 2655–2663. 12 indexed citations
17.
Ceredig, Rhodri, Jane E. Allan, Zsuzsanna Tabi, Felicity Lynch, & Peter C. Doherty. (1987). Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis.. The Journal of Experimental Medicine. 165(6). 1539–1551. 65 indexed citations
18.
Doherty, Peter C., et al.. (1986). Characteristics of the inflammatory process in murine lymphocytic choriomeningitis. Medical Microbiology and Immunology. 175(2-3). 193–195. 3 indexed citations
19.
Allan, Jane E. & Peter C. Doherty. (1985). Consequences of a single Ir-gene defect for the pathogenesis of lymphocytic choriomeningitis. Immunogenetics. 21(6). 581–589. 33 indexed citations
20.
Allan, Jane E. & Peter C. Doherty. (1985). Immune T cells can protect or induce fatal neurological disease in murine lymphocytic choriomeningitis. Cellular Immunology. 90(2). 401–407. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026